 Aged, 80 and over
"Aged, 80 and over" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 80 years of age and older.
| Descriptor ID |
D000369
|
| MeSH Number(s) |
M01.060.116.100.080
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aged, 80 and over".
Below are MeSH descriptors whose meaning is more specific than "Aged, 80 and over".
This graph shows the total number of publications written about "Aged, 80 and over" by people in this website by year, and whether "Aged, 80 and over" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 32 | 32 | | 1996 | 0 | 26 | 26 | | 1997 | 0 | 37 | 37 | | 1998 | 0 | 44 | 44 | | 1999 | 0 | 46 | 46 | | 2000 | 0 | 55 | 55 | | 2001 | 0 | 46 | 46 | | 2002 | 0 | 36 | 36 | | 2003 | 1 | 84 | 85 | | 2004 | 0 | 81 | 81 | | 2005 | 0 | 127 | 127 | | 2006 | 0 | 151 | 151 | | 2007 | 1 | 164 | 165 | | 2008 | 0 | 161 | 161 | | 2009 | 0 | 179 | 179 | | 2010 | 1 | 212 | 213 | | 2011 | 0 | 232 | 232 | | 2012 | 0 | 225 | 225 | | 2013 | 1 | 251 | 252 | | 2014 | 0 | 238 | 238 | | 2015 | 2 | 297 | 299 | | 2016 | 0 | 310 | 310 | | 2017 | 0 | 306 | 306 | | 2018 | 0 | 319 | 319 | | 2019 | 0 | 343 | 343 | | 2020 | 0 | 265 | 265 | | 2021 | 0 | 210 | 210 | | 2022 | 0 | 45 | 45 | | 2023 | 0 | 39 | 39 | | 2024 | 0 | 18 | 18 | | 2025 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Aged, 80 and over" by people in Profiles.
-
Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019. Nat Commun. 2025 May 07; 16(1):4235.
-
Schaich CL, Chappell MC, Shotwell MS, Joly MM, Gibbs KW, Barksdale A, Douglas IS, Chen P, Levitt JE, Puskarich MA, Rice TW, Harkins MS, Hudock KM, Lanspa MJ, Ginde AA, Self WH, Collins SP, Files DC. The circulating renin-angiotensin system and mortality among patients hospitalized for COVID-19: a mechanistic substudy of the ACTIV-4 Host Tissue trials. Am J Physiol Lung Cell Mol Physiol. 2025 Mar 01; 328(3):L405-L412.
-
Rauzi MR, Abbate LM, Lum HD, Cook PF, Stevens-Lapsley JE. Multicomponent telerehabilitation programme for older veterans with multimorbidity: a programme evaluation. BMJ Mil Health. 2025 Jan 28; 171(1):33-39.
-
Thompson Iii GR, Chastain DB, Ferraz C, Alhayek S, Salinas JL, Sillau S, Stenehjem EA, Henao-Mart?nez AF. Mortality patterns in candidemia: Insights from a multispecies analysis using a global research network. Med Mycol. 2024 Dec 27; 63(1).
-
Garbin AJ, Falvey JR, Cumbler E, Derlein D, Currier D, Nordon-Craft A, Will R, Olivos M, Forster JE, Mangione KK, Stevens-Lapsley JE. Progressive Multicomponent Intervention for Older Adults in Home Health Settings Following Hospitalization: Randomized Clinical Trial. Phys Ther. 2024 Dec 06; 104(12).
-
Derman BA, Major A, Cooperrider J, Jiang K, Ramsland A, Karrison T, Kubicki T, Jakubowiak AJ. Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP). Blood Cancer J. 2024 10 07; 14(1):170.
-
Panian J, Saidian A, Hakimi K, Ajmera A, Anderson WJ, Barata P, Berg S, Signoretti S, Lee Chang S, D'Andrea V, George D, Dzimitrowicz H, El Zarif T, Emamekhoo H, Gross E, Kilari D, Lam E, Lashgari I, Psutka S, Rauterkus GP, Shabaik A, Thapa B, Wang L, Weise N, Yim K, Zhang T, Derweesh I, McKay RR. Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy. Oncologist. 2024 Oct 03; 29(10):870-877.
-
French JD, Haugen BR, Worden FP, Bowles DW, Gianoukakis AG, Konda B, Dadu R, Sherman EJ, McCue S, Foster NR, Nikiforov YE, Farias TDJ, Norman PJ, Wirth LJ. Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers. Clin Cancer Res. 2024 Sep 03; 30(17):3757-3767.
-
Miller E, Biesemier A, Coomes DM, Raghavan SS. PRAME Expression in Merkel Cell Carcinoma. Am J Surg Pathol. 2024 Oct 01; 48(10):1270-1276.
-
Bhansali RS, Ellin F, Relander T, Cao M, Li W, Long Q, Ganesan N, Stuver R, Horwitz SM, Wudhikarn K, Hwang SR, Bennani NN, Chavez J, Sokol L, Saeed H, Duan F, Porcu P, Pullarkat P, Mehta-Shah N, Zain JM, Ruiz M, Brammer JE, Prakash R, Iyer SP, Olszewski AJ, Major A, Riedell PA, Smith SM, Goldin C, Haverkos B, Hu B, Zhuang TZ, Allen PB, Toama W, Janakiram M, Brooks TR, Jagadeesh D, Hariharan N, Goodman AM, Hartman G, Ghione P, Fayyaz F, Rhodes JM, Chong EA, Gerson JN, Landsburg DJ, Nasta SD, Schuster SJ, Svoboda J, Jerkeman M, Barta SK. The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas. Blood Adv. 2024 07 09; 8(13):3507-3518.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|